Carlyle-backed Claris Lifesciences makes strong debut as IPO looms
Carlyle Group-backed Claris Lifesciences Limited, maker of injectable medications, has raised an initial INR539 million ($11.8 million) through share sales to four anchor investors, coming as the company looks to raise a total of INR3 billion ($65.7 million) in its IPO process that began today, according to reports.
Claris confirmed that it had sold 1.84 million equity shares. Media suggested that the investors are Tree Line Asia Master Fund, Ashoka Flowering Tree Mauritius, Indea Capital and Long Term Opportunities...
More on South Asia
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.